~20% of patients presenting with Stage 3 NSCLC to a primary care provider or pulmonologist never receive care from other multidisciplinary team members, including oncologists4
“Make sure that patients are referred…Get them in the door to the medical oncologist and radiation oncologist so we can provide the best care.”
In one study (N=75), 20% of patients with early-stage NSCLC were found to be understaged, potentially leading to suboptimal treatment decisions.10,11†
“If we’re not able to stage our patients, we could be undertreating them, overtreating them.”
NSCLC=non-small cell lung cancer; CRT=chemoradiotherapy; PCP=primary care provider.
*The views and opinions expressed in the Art of CRT video series are those of the individual panel members and do not represent the views or opinions of AstraZeneca. These videos contain anecdotal information gathered from a discussion with 8 physicians and nurses based on their opinions/experiences. Recommendations are general and may vary with patients.
†Patients underwent staging by endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA).